InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,156.81
(
0.57%
)
US TECH 100
17,522.00
(
0.59%
)
Dow Jones
38,805.53
(
0.34%
)
Brent Oil
83.43
(
0.37%
)
Bitcoin
64,030.21
(
0.05%
)
Post# of 251721
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 826
Posts 119569
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: dewophile post# 190972

Tuesday, 03/15/2016 8:54:01 AM

Tuesday, March 15, 2016 8:54:01 AM

Post# of 251721
CLCD adds director who previously worked for OVAS—bad sign?

http://finance.yahoo.com/news/colucid-pharmaceuticals-announces-election-alison-120000816.html

Alison Lawton is currently the Chief Operating Officer (COO) at Aura Biosciences and prior to this was COO of OvaScience, Inc. Previously she was with Genzyme Corp. for 21 years where she had a number of roles including Senior Vice President and General Manager of the Sanofi Biosurgery Business Unit, Global Head of Market Access at Genzyme which included Regulatory Affairs, Global Health Outcomes and Strategic Pricing, Global Public Policy, and Global Product Safety & Risk Management.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up